Current trends in botulism in the United States.
D001904:Botulinum Antitoxin / Q000009:adverse effects / Q000627:therapeutic use; D001905:Botulinum Toxins / Q000145:classification / Q000302:isolation & purification; D001906:Botulism / Q000175:diagnosis / Q000188:drug therapy / Q000453:epidemiology* / Q000401:mortality; D003014:Clostridium botulinum / Q000302:isolation & purification; D003937:Diagnosis, Differential; D004196:Disease Outbreaks / Q000453:epidemiology*; D004576:Electromyography; D005243:Feces / Q000382:microbiology; D005260:Female; D005516:Food Microbiology; D005517:Foodborne Diseases; D006801:Humans; D008297:Male; D011247:Pregnancy; D014481:United States; D014946:Wound Infection / Q000382:microbiology
D001904:Botulinum Antitoxin; D001905:Botulinum Toxins